AtriCure (ATRC) Insider Trading & Ownership $27.02 -0.30 (-1.10%) (As of 10/9/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AtriCure (NASDAQ:ATRC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$111,250.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$632,145.40 Get ATRC Insider Trade Alerts Want to know when executives and insiders are buying or selling AtriCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATRC Insider Buying and Selling by Quarter Ad The Oxford ClubOil Prices Surge Due to Israel-Iran ConflictHeightened tension in the Middle East has created a huge supply shock to the global oil industry. But… I’ve found a new way to invest in oil right here in the US.All the details are right here. AtriCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2024Maggie YuenDirectorSell3,500$24.07$84,245.00 7/19/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$24.17$1,001 - $15,0006/18/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$21.20$1,001 - $15,0005/30/2024Salvatore PriviteraInsiderBuy5,000$22.25$111,250.00 5/1/2024Justin J NozneskyInsiderSell1,500$24.09$36,135.00 4/1/2024Justin J NozneskyInsiderSell1,500$30.39$45,585.00 3/18/2024Karl S DahlquistInsiderSell1,885$32.16$60,621.60 3/12/2024Justin J NozneskyInsiderSell1,500$36.72$55,080.00 3/5/2024Karl S DahlquistInsiderSell8,231$37.36$307,510.16 11/1/2023Karl S DahlquistInsiderSell1,248$34.43$42,968.64 (Data available from 1/1/2013 forward) ATRC Insider Trading Activity - Frequently Asked Questions Who is on AtriCure's Insider Roster? The list of insiders at AtriCure includes Angela L Wirick, Justin J Noznesky, Karen Prange, Karl S Dahlquist, Maggie Yuen, Mark A Collar, Salvatore Privitera, Tonya Austin, and Vinayak Doraiswamy. Learn more on insiders at ATRC. What percentage of AtriCure stock is owned by insiders? 3.20% of AtriCure stock is owned by insiders. Learn more on ATRC's insider holdings. Which AtriCure insiders have been buying company stock? The following insider purchased ATRC shares in the last 24 months: Salvatore Privitera ($111,250.00). How much insider buying is happening at AtriCure? Insiders have purchased a total of 5,000 ATRC shares in the last 24 months for a total of $111,250.00 bought. Which AtriCure insiders have been selling company stock? The following insiders have sold ATRC shares in the last 24 months: Justin J Noznesky ($136,800.00), Karen Prange ($34,145.57), Karl S Dahlquist ($673,053.59), and Maggie Yuen ($287,128.52). How much insider selling is happening at AtriCure? Insiders have sold a total of 29,229 AtriCure shares in the last 24 months for a total of $1,131,127.68 sold. Which members of congress are trading AtriCure? Josh Gottheimer (D-NJ) has bought shares of AtriCure in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000. AtriCure Key ExecutivesMr. Michael H. Carrel (Age 53)CEO, President & Director Compensation: $2.01MMs. Angela L. Wirick CPA (Age 46)Chief Financial Officer Compensation: $841.54kMr. Douglas J. Seith (Age 58)Chief Operating Officer Compensation: $1.2MMr. Salvatore Privitera J.D. (Age 57)Chief Technical Officer Compensation: $758.8k1 recent tradesMr. Karl S. Dahlquist CCEP (Age 53)J.D., Chief Legal Officer Compensation: $762.39kDr. Vinayak Doraiswamy Ph.D. (Age 52)Chief Scientific Officer Compensation: $777.66kValerie Storch-WillhausVice President of Corporate Marketing & CommunicationsMr. Justin J. Noznesky (Age 46)Chief Marketing & Strategy Officer Compensation: $644.73k1 recent tradesMs. Deborah Yount (Age 58)Chief Human Resources Officer Compensation: $498.36k More Insider Trading Tools from MarketBeat Related Companies: ATRI Insider Trading LUNG Insider Trading INO Insider Trading ITGR Insider Trading IART Insider Trading ATEC Insider Trading OFIX Insider Trading SRDX Insider Trading ANGO Insider Trading ARAY Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now This page (NASDAQ:ATRC) was last updated on 10/10/2024 by MarketBeat.com Staff From Our PartnersBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredAI Expert Reveals New PickWhy You Shouldn't Pour All Your Money Into Nvidia Jeff Brown, who predicted Nvidia's rise, warns against pu...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.